Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Abivax SA Sponsored ADR stock logo
ABVX
Abivax
$77.30
+3.8%
$35.28
$4.77
$78.49
$5.85B0.56652,895 shs1.19 million shs
Apria, Inc. stock logo
APR
Apria
$37.50
$37.45
$22.36
$40.00
$1.34BN/A682,285 shsN/A
CRISPR Therapeutics AG stock logo
CRSP
CRISPR Therapeutics
$54.50
+3.2%
$54.49
$30.04
$71.13
$4.96B1.82.61 million shs1.32 million shs
Teleflex Incorporated stock logo
TFX
Teleflex
$129.29
+3.8%
$117.96
$108.90
$249.90
$5.72B1.08789,962 shs213,514 shs
7 Stocks to Buy And Hold Forever Cover

Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Abivax SA Sponsored ADR stock logo
ABVX
Abivax
+3.53%+7.00%+644.30%+1,212.70%+544.42%
Apria, Inc. stock logo
APR
Apria
0.00%0.00%0.00%0.00%0.00%
CRISPR Therapeutics AG stock logo
CRSP
CRISPR Therapeutics
-0.47%-10.20%-19.88%+43.30%+5.66%
Teleflex Incorporated stock logo
TFX
Teleflex
-0.87%+2.34%+8.33%+2.96%-47.74%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Abivax SA Sponsored ADR stock logo
ABVX
Abivax
2.877 of 5 stars
3.63.00.00.03.30.80.6
Apria, Inc. stock logo
APR
Apria
N/AN/AN/AN/AN/AN/AN/AN/A
CRISPR Therapeutics AG stock logo
CRSP
CRISPR Therapeutics
3.7962 of 5 stars
4.33.00.00.02.83.30.6
Teleflex Incorporated stock logo
TFX
Teleflex
4.5794 of 5 stars
1.05.02.53.94.13.31.9
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Abivax SA Sponsored ADR stock logo
ABVX
Abivax
3.13
Buy$92.3319.46% Upside
Apria, Inc. stock logo
APR
Apria
0.00
N/AN/AN/A
CRISPR Therapeutics AG stock logo
CRSP
CRISPR Therapeutics
2.50
Moderate Buy$71.6031.38% Upside
Teleflex Incorporated stock logo
TFX
Teleflex
2.00
Hold$141.579.50% Upside

Current Analyst Ratings Breakdown

Latest APR, TFX, ABVX, and CRSP Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
8/7/2025
CRISPR Therapeutics AG stock logo
CRSP
CRISPR Therapeutics
HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$65.00 ➝ $80.00
8/6/2025
CRISPR Therapeutics AG stock logo
CRSP
CRISPR Therapeutics
Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetEqual Weight ➝ Equal Weight$42.00 ➝ $56.00
8/5/2025
CRISPR Therapeutics AG stock logo
CRSP
CRISPR Therapeutics
Chardan Capital
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$82.00
8/5/2025
CRISPR Therapeutics AG stock logo
CRSP
CRISPR Therapeutics
Royal Bank Of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetSector Perform ➝ Sector Perform$38.00 ➝ $42.00
8/1/2025
Teleflex Incorporated stock logo
TFX
Teleflex
Royal Bank Of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetSector Perform ➝ Sector Perform$130.00 ➝ $135.00
8/1/2025
Teleflex Incorporated stock logo
TFX
Teleflex
Mizuho
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetNeutral ➝ Neutral$130.00 ➝ $135.00
8/1/2025
Teleflex Incorporated stock logo
TFX
Teleflex
Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetEqual Weight ➝ Equal Weight$137.00 ➝ $131.00
7/29/2025
Abivax SA Sponsored ADR stock logo
ABVX
Abivax
Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOverweight ➝ Overweight$70.00 ➝ $112.00
7/23/2025
Abivax SA Sponsored ADR stock logo
ABVX
Abivax
Leerink Partners
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Set Price TargetOutperform ➝ Outperform$74.00
7/23/2025
Abivax SA Sponsored ADR stock logo
ABVX
Abivax
Lifesci Capital
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOutperform ➝ Outperform$45.00 ➝ $101.00
7/23/2025
Abivax SA Sponsored ADR stock logo
ABVX
Abivax
Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOverweight ➝ Overweight$42.00 ➝ $70.00
(Data available from 8/22/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Abivax SA Sponsored ADR stock logo
ABVX
Abivax
N/AN/AN/AN/A$0.69 per shareN/A
Apria, Inc. stock logo
APR
Apria
$1.15B1.17$5.27 per share7.12$1.12 per share33.48
CRISPR Therapeutics AG stock logo
CRSP
CRISPR Therapeutics
$35M141.62N/AN/A$18.81 per share2.90
Teleflex Incorporated stock logo
TFX
Teleflex
$3.05B1.87$26.12 per share4.95$96.01 per share1.35
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Abivax SA Sponsored ADR stock logo
ABVX
Abivax
-$190.71MN/A0.00N/AN/AN/AN/AN/AN/A
Apria, Inc. stock logo
APR
Apria
$64.88MN/A0.0020.49N/A5.66%586.18%9.23%N/A
CRISPR Therapeutics AG stock logo
CRSP
CRISPR Therapeutics
-$366.25M-$5.43N/AN/AN/A-1,229.43%-20.05%-17.09%11/4/2025 (Estimated)
Teleflex Incorporated stock logo
TFX
Teleflex
$69.68M$4.2530.478.521.756.31%15.08%8.85%10/30/2025 (Estimated)

Latest APR, TFX, ABVX, and CRSP Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/4/2025Q2 2025
CRISPR Therapeutics AG stock logo
CRSP
CRISPR Therapeutics
-$1.47-$1.29+$0.18-$2.40$6.44 million$0.89 million
7/31/2025Q2 2025
Teleflex Incorporated stock logo
TFX
Teleflex
$3.36$3.73+$0.37$2.77$771.53 million$780.90 million
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Abivax SA Sponsored ADR stock logo
ABVX
Abivax
N/AN/AN/AN/AN/A
Apria, Inc. stock logo
APR
Apria
N/AN/AN/AN/AN/A
CRISPR Therapeutics AG stock logo
CRSP
CRISPR Therapeutics
N/AN/AN/AN/AN/A
Teleflex Incorporated stock logo
TFX
Teleflex
$1.361.05%N/A32.00%N/A

Latest APR, TFX, ABVX, and CRSP Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
7/31/2025
Teleflex Incorporated stock logo
TFX
Teleflex
quarterly$0.341.19%8/15/20258/15/20259/15/2025
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Abivax SA Sponsored ADR stock logo
ABVX
Abivax
1.29
1.25
1.25
Apria, Inc. stock logo
APR
Apria
8.58
1.09
1.06
CRISPR Therapeutics AG stock logo
CRSP
CRISPR Therapeutics
N/A
16.61
16.61
Teleflex Incorporated stock logo
TFX
Teleflex
0.42
2.41
1.44

Institutional Ownership

CompanyInstitutional Ownership
Abivax SA Sponsored ADR stock logo
ABVX
Abivax
47.91%
Apria, Inc. stock logo
APR
Apria
N/A
CRISPR Therapeutics AG stock logo
CRSP
CRISPR Therapeutics
69.20%
Teleflex Incorporated stock logo
TFX
Teleflex
95.62%

Insider Ownership

CompanyInsider Ownership
Abivax SA Sponsored ADR stock logo
ABVX
Abivax
N/A
Apria, Inc. stock logo
APR
Apria
N/A
CRISPR Therapeutics AG stock logo
CRSP
CRISPR Therapeutics
4.30%
Teleflex Incorporated stock logo
TFX
Teleflex
1.40%
CompanyEmployeesShares OutstandingFree FloatOptionable
Abivax SA Sponsored ADR stock logo
ABVX
Abivax
6175.55 millionN/ANot Optionable
Apria, Inc. stock logo
APR
Apria
6,08035.65 millionN/ANot Optionable
CRISPR Therapeutics AG stock logo
CRSP
CRISPR Therapeutics
46090.95 million87.04 millionOptionable
Teleflex Incorporated stock logo
TFX
Teleflex
14,10044.19 million43.57 millionOptionable

Recent News About These Companies

1 Healthcare Stock Worth Investigating and 2 Facing Challenges

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Abivax stock logo

Abivax NASDAQ:ABVX

$77.30 +2.87 (+3.85%)
As of 03:22 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

ABIVAX Société Anonyme, a clinical-stage biotechnology company, focuses on developing therapeutics that harness the body's natural regulatory mechanisms to stablize the immune response in patients with chronic inflammatory diseases. The company is evaluating its lead drug candidate, obefazimod, in Phase 3 clinical trials for the treatment of moderately to severely active ulcerative colitis in adults. ABIVAX Société Anonyme was incorporated in 2013 and is headquartered in Paris, France.

Apria stock logo

Apria NYSE:APR

Apria, Inc. provides integrated home healthcare equipment and related services in the United States. The company offers home respiratory therapies, including the supply of stationary and portable home oxygen equipment, and non-invasive ventilators; obstructive sleep apnea therapy devices comprising continuous positive airway pressure and bi-level positive airway pressure devices, and patient support services; and negative pressure wound therapy products. It also provides a range of home medical equipment and other products, and services for patients with home care needs; and clinical and administrative support services, and related products and supplies to patients. Apria, Inc. was incorporated in 2018 and is headquartered in Indianapolis, Indiana. As of March 29, 2022, Apria, Inc. operates as a subsidiary of Byram Healthcare Centers, Inc.

CRISPR Therapeutics stock logo

CRISPR Therapeutics NASDAQ:CRSP

$54.50 +1.68 (+3.18%)
As of 03:22 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

CRISPR Therapeutics is a gene-editing company focused on developing transformative gene-based medicines for serious diseases using its proprietary CRISPR/Cas9 platform. CRISPR/Cas9 is a revolutionary gene-editing technology that allows for precise, directed changes to genomic DNA. CRISPR Therapeutics has established a portfolio of therapeutic programs across a broad range of disease areas including hemoglobinopathies, oncology, regenerative medicine and rare diseases. To accelerate and expand its efforts, CRISPR Therapeutics has established strategic collaborations with companies including Bayer, Vertex Pharmaceuticals and ViaCyte, Inc. CRISPR Therapeutics AG is headquartered in Zug, Switzerland, with its wholly-owned U.S. subsidiary, CRISPR Therapeutics, Inc., and R&D operations based in Cambridge, Massachusetts, and business offices in San Francisco, California and London, United Kingdom. For more information, please visit www.crisprtx.com.

Teleflex stock logo

Teleflex NYSE:TFX

$129.29 +4.68 (+3.76%)
As of 03:23 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site. It also offers interventional products, which consists of various coronary catheters, structural heart support devices, and peripheral intervention and mechanical circulatory support platform that are used by interventional cardiologists and radiologists, and vascular surgeons; and Arrow branded pumps and catheters, Guideline, Turnpike, and Trapliner catheters, the Manta Vascular Closure, and Arrow Oncontrol devices. The company provides anesthesia products, such as airway and pain management products to support hospital, emergency medicine, and military channels; and surgical products, including metal and polymer ligation clips, and fascial closure surgical systems that are used in laparoscopic surgical procedures, percutaneous surgical systems, and other surgical instruments. It also offers interventional urology products comprising the UroLift System, an invasive technology for treating lower urinary tract symptoms due to benign prostatic hyperplasia; respiratory products, including oxygen and aerosol therapies, spirometry, and ventilation management products for use in various care settings; urology products, such as catheters, urine collectors, and catheterization accessories and products for operative endourology; and bladder management services. The company serves hospitals and healthcare providers, medical device manufacturers, and home care markets. Teleflex Incorporated was incorporated in 1943 and is headquartered in Wayne, Pennsylvania.